ZOOMMED INC. Inactive Instrument
ZoomMed Inc. Share Price Toronto S.E.
Equities
ZMD
CA98977R1038
Advanced Medical Equipment & Technology
| Sales 2022 | 11.15K 8.14K 680K | Sales 2023 | 13.01K 9.5K 793K | Capitalization | 2.03M 1.49M 124M |
|---|---|---|---|---|---|
| Net income 2022 | -1M -730K -60.96M | Net income 2023 | - 0 0 | EV / Sales 2022 | 168 x |
| Net cash position 2022 | 161K 117K 9.79M | Net Debt 2023 | 393K 287K 23.94M | EV / Sales 2023 | 186 x |
| P/E ratio 2022 |
-1.66
x | P/E ratio 2023 |
11.6
x | Employees | - |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 93.02% |
More Fundamentals
* Assessed data
More news
More news
| Managers | Title | Age | Since |
|---|---|---|---|
Yves Marmet
CEO | Chief Executive Officer | - | 01/05/01 |
| Director of Finance/CFO | - | 01/05/01 | |
Sébastie Ouellet
CTO | Chief Tech/Sci/R&D Officer | - | 01/05/01 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Robert Powell
BRD | Director/Board Member | - | 01/05/01 |
André Marmet
PRN | Corporate Officer/Principal | - | 01/05/01 |
| Director of Finance/CFO | - | 01/05/01 |
ZoomMed Inc. is a Canada-based company, which builds and operates ZoomMedâs Communication Network, a clinical interoperable information exchange network between physicians and the various other stakeholders of the healthcare sector, such as pharmacists, specialists, pharmaceutical corporations and private insurers.
Calendar
27/09/2024
- Q4 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -3.77% | 29.79B | |
| +45.89% | 9.69B | |
| +35.36% | 4.5B | |
| -39.30% | 2.38B | |
| -8.48% | 1.63B | |
| -31.30% | 1.2B | |
| -43.22% | 992M | |
| +7.02% | 953M | |
| -46.41% | 763M |
